Abstract
Pulmonary surfactant is a complex mixture of lipids and proteins that reduces the surface tension at the air–liquid interface. In addition to its biophysical function, some surfactant components play an important role for the innate and adaptive immunity of the lung. A negative modulation of the surfactant function was observed in allergic asthma leading to the assumption that the therapeutic application of surfactant components might be beneficial in this disease. So far, there are a number of preclinical and already some clinical studies demonstrating various effects of different surfactant components that were administered with preventive or therapeutic aim in allergic asthma. This review summarizes the current knowledge on the possibilities to treat allergic asthma with surfactant components.
Similar content being viewed by others
References
Alcorn JF, Wright JR (2004) Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem 279:30871–30879
Allen MJ, Harbeck R, Smith B, Voelker DR, Mason RJ (1999) Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia. Infect Immun 67:4563–4569
Babu KS, Woodcock DA, Smith SE, Staniforth JN, Holgate ST, Conway JH (2003) Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. Eur Respir J 21:1046–1049
Beatty AL, Malloy JL, Wright JR (2005) Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro. Am J Respir Cell Mol Biol 32:128–134
Borron P, McCormack FX, Elhalwagi BM, Chroneos ZC, Lewis JF, Zhu S, Wright JR, Shepherd VL, Possmayer F, Inchley K, Fraher LJ (1998a) Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am J Physiol 275:L679–L686
Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ (1998b) Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol 161:4599–4603
Brandt EB, Mingler MK, Stevenson MD, Wang N, Khurana Hershey GK, Whitsett JA, Rothenberg ME (2008) Surfactant protein D alters allergic lung responses in mice and human subjects. J Allergy Clin Immunol 121:1140–1147
Brinker KG, Martin E, Borron P, Mostaghel E, Doyle C, Harding CV, Wright JR (2001) Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 281:L1453–L1463
Brinker KG, Garner H, Wright JR (2003) Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 284:L232–L241
Cao Y, Tao JQ, Bates SR, Beers MF, Haczku A (2004) IL-4 induces production of the lung collectin surfactant protein-D. J Allergy Clin Immunol 113:439–444
Cheng G, Ueda T, Nakajima H, Nakajima A, Kinjyo S, Motojima S, Fukuda T (1998) Suppressive effects of SP-A on ionomycin-induced IL-8 production and release by eosinophils. Int Arch Allergy Immunol 117(Suppl 1):59–62
Cheng G, Ueda T, Numao T, Kuroki Y, Nakajima H, Fukushima Y, Motojima S, Fukuda T (2000) Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur Respir J 16:831–835
Crouch E, Wright JR (2001) Surfactant proteins a and d and pulmonary host defense. Annu.Rev.Physiol 63:521–554
Deb R, Shakib F, Reid K, Clark H (2007) Major house dust mite allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 degrade and inactivate lung surfactant proteins A and D. J Biol Chem 282:36808–36819
Erpenbeck VJ, Hagenberg A, Dulkys Y, Elsner J, Balder R, Krentel H, Discher M, Braun A, Krug N, Hohlfeld JM (2004) Natural porcine surfactant augments airway inflammation after allergen challenge in patients with asthma. Am J Respir Crit Care Med 169:578–586
Erpenbeck VJ, Malherbe DC, Sommer S, Schmiedl A, Steinhilber W, Ghio AJ, Krug N, Wright JR, Hohlfeld JM (2005) Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules. Am J Physiol Lung Cell Mol Physiol 288:L692–L698
Erpenbeck VJ, Schmidt R, Gunther A, Krug N, Hohlfeld JM (2006a) Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma. Allergy 61:598–604
Erpenbeck VJ, Ziegert M, Cavalet-Blanco D, Martin C, Baelder R, Glaab T, Braun A, Steinhilber W, Luettig B, Uhlig S, Hoymann HG, Krug N, Hohlfeld JM (2006b) Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin.Exp.Allergy 36:930–940
Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS (1999) Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 163:312–321
Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G (1987) Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62:429–437
Haczku A, Cao Y, Vass G, Kierstein S, Nath P, Atochina-Vasserman EN, Scanlon ST, Li L, Griswold DE, Chung KF, Poulain FR, Hawgood S, Beers MF, Crouch EC (2006) IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol 176:3557–3565
Hamm H, Kroegel C, Hohlfeld J (1996) Surfactant: a review of its functions and relevance in adult respiratory disorders. Respir Med 90:251–270
Hansen S, Lo B, Evans K, Neophytou P, Holmskov U, Wright JR (2007) Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol 36:94–102
Hartshorn KL, White MR, Crouch EC (2002) Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria. Infect Immun 70:6129–6139
Heeley EL, Hohlfeld JM, Krug N, Postle AD (2000) Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. Am J Physiol Lung Cell Mol Physiol 278:L305–L311
Hite RD, Seeds MC, Bowton DL, Grier BL, Safta AM, Balkrishnan R, Waite BM, Bass DA (2005a) Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol 288:L610–L617
Hite RD, Seeds MC, Jacinto RB, Grier BL, Waite BM, Bass DA (2005b) Lysophospholipid and fatty acid inhibition of pulmonary surfactant: non-enzymatic models of phospholipase A2 surfactant hydrolysis. Biochim Biophys Acta 1720:14–21
Hite RD, Seeds MC, Safta AM, Jacinto RB, Gyves JI, Bass DA, Waite BM (2005c) Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction. Am.J.Physiol Lung Cell Mol Physiol 288:L618–L624
Hohlfeld J, Hoymann HG, Molthan J, Fabel H, Heinrich U (1997) Aerosolized surfactant inhibits acetylcholine-induced airway obstruction in rats. Eur Respir J 10:2198–2203
Hohlfeld JM, Ahlf K, Enhorning G, Balke K, Erpenbeck VJ, Petschallies J, Hoymann HG, Fabel H, Krug N (1999) Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 159:1803–1809
Holmskov U, Thiel S, Jensenius JC (2003) Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 21:547–578
Homer RJ, Zheng T, Chupp G, He S, Zhu Z, Chen Q, Ma B, Hite RD, Gobran LI, Rooney SA, Elias JA (2002) Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol 283:L52–L59
Hortobagyi L, Kierstein S, Krytska K, Zhu X, Das AM, Poulain F, Haczku A (2008) Surfactant protein D inhibits TNF-alpha production by macrophages and dendritic cells in mice. J Allergy Clin Immunol 122:521–528
Jain-Vora S, Wert SE, Temann UA, Rankin JA, Whitsett JA (1997) Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. Am J Respir Cell Mol Biol 17:541–551
Jarjour NN, Enhorning G (1999) Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med 160:336–341
Koetzler R, Saifeddine M, Yu Z, Schurch FS, Hollenberg MD, Green FH (2006) Surfactant as an airway smooth muscle relaxant. Am J Respir Cell Mol Biol 34:609–615
Koopmans JG, van der Zee JS, Krop EJ, Lopuhaa CE, Jansen HM, Batenburg JJ (2004) Serum surfactant protein D is elevated in allergic patients. Clin Exp Allergy 34:1827–1833
Kremlev SG, Umstead TM, Phelps DS (1994) Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol 267:L357–L364
Kurashima K, Ogawa H, Ohka T, Fujimura M, Matsuda T, Kobayashi T (1991) A pilot study of surfactant inhalation in the treatment of asthmatic attack. Arerugi 40:160–163
Kurashima K, Fujimura M, Matsuda T, Kobayashi T (1997a) Surface activity of sputum from acute asthmatic patients. Am J Respir Crit Care Med 155:1254–1259
Kurashima K, Fujimura M, Tsujiura M, Matsuda T (1997b) Effect of surfactant inhalation on allergic bronchoconstriction in guinea pigs. Clin Exp Allergy 27:337–342
Kwatia MA, Doyle CB, Cho W, Enhorning G, Ackerman SJ (2007) Combined activities of secretory phospholipases and eosinophil lysophospholipases induce pulmonary surfactant dysfunction by phospholipid hydrolysis. J Allergy Clin Immunol 119:838–847
LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA, Korfhagen TR (1999) Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 20:279–286
Liu CF, Chen YL, Shieh CC, Yu CK, Reid KB, Wang JY (2005) Therapeutic effect of surfactant protein D in allergic inflammation of mite-sensitized mice. Clin Exp Allergy 35:515–521
Madan T, Eggleton P, Kishore U, Strong P, Aggrawal SS, Sarma PU, Reid KB (1997a) Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 65:3171–3179
Madan T, Kishore U, Shah A, Eggleton P, Strong P, Wang JY, Aggrawal SS, Sarma PU, Reid KB (1997b) Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol 110:241–249
Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, Reid KB, Sarma PU (2001) Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 107:467–475
Madan T, Reid KB, Singh M, Sarma PU, Kishore U (2005) Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J Immunol 174:6943–6954
Mahajan L, Madan T, Kamal N, Singh VK, Sim RB, Telang SD, Ramchand CN, Waters P, Kishore U, Sarma PU (2008) Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages. Int Immunol 20:993–1007
Malherbe DC, Erpenbeck VJ, Abraham SN, Crouch EC, Hohlfeld JM, Wright JR (2005) Surfactant protein D decreases pollen-induced IgE-dependent mast cell degranulation. Am J Physiol Lung Cell Mol Physiol 289:L856–L866
Malhotra R, Haurum J, Thiel S, Jensenius JC, Sim RB (1993) Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A). Biosci Rep 13:79–90
Malloy JL, Veldhuizen RA, Thibodeaux BA, O’Callaghan RJ, Wright JR (2005) Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am.J.Physiol Lung Cell Mol Physiol 288:L409–L418
Mishra A, Weaver TE, Beck DC, Rothenberg ME (2001) Interleukin-5-mediated allergic airway inflammation inhibits the human surfactant protein C promoter in transgenic mice. J Biol Chem 276:8453–8459
Nadesalingam J, Reid KB, Palaniyar N (2005) Collectin surfactant protein D binds antibodies and interlinks innate and adaptive immune systems. FEBS Lett 579:4449–4453
Oetomo SB, Dorrepaal C, Bos H, Gerritsen J, van der Mark TW, Koeter GH, van Aalderen WM (1996) Surfactant nebulization does not alter airflow obstruction and bronchial responsiveness to histamine in asthmatic children. Am J Respir Crit Care Med 153:1148–1152
Palaniyar N, Clark H, Nadesalingam J, Shih MJ, Hawgood S, Reid KB (2005) Innate immune collectin surfactant protein D enhances the clearance of DNA by macrophages and minimizes anti-DNA antibody generation. J Immunol 174:7352–7358
Plotz SG, Traidl-Hoffmann C, Feussner I, Kasche A, Feser A, Ring J, Jakob T, Behrendt H (2004) Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators. J Allergy Clin Immunol 113:1152–1160
Restrepo CI, Dong Q, Savov J, Mariencheck WI, Wright JR (1999) Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol.Biol 21:576–585
Schaub B, Westlake RM, He H, Arestides R, Haley KJ, Campo M, Velasco G, Bellou A, Hawgood S, Poulain FR, Perkins DL, Finn PW (2004) Surfactant protein D deficiency influences allergic immune responses. Clin Exp Allergy 34:1819–1826
Seeger W, Grube C, Gunther A, Schmidt R (1993) Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6:971–977
Singh M, Madan T, Waters P, Parida SK, Sarma PU, Kishore U (2003) Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens. Immunol Lett 86:299–307
Strong P, Townsend P, Mackay R, Reid KB, Clark HW (2003) A recombinant fragment of human SP-D reduces allergic responses in mice sensitized to house dust mite allergens. Clin Exp Immunol 134:181–187
Takeda K, Miyahara N, Rha YH, Taube C, Yang ES, Joetham A, Kodama T, Balhorn AM, Dakhama A, Duez C, Evans AJ, Voelker DR, Gelfand EW (2003) Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am J Respir Crit Care Med 168:783–789
van de Graaf EA, Jansen HM, Lutter R, Alberts C, Kobesen J, de Vries IJ, Out TA (1992) Surfactant protein A in bronchoalveolar lavage fluid. J Lab Clin Med 120:252–263
van Helden HP, Kuijpers WC, Diemel RV (2004) Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal Toxicol 16:537–548
Wang JY, Reid KB (2007) The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 212:417–425
Wang JY, Kishore U, Lim BL, Strong P, Reid KB (1996) Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin Exp Immunol 106:367–373
Wang JY, Shieh CC, You PF, Lei HY, Reid KB (1998) Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 158:510–518
Whitsett JA, Nogee LM, Weaver TE, Horowitz AD (1995) Human surfactant protein B: structure, function, regulation, and genetic disease. Physiol Rev 75:749–757
Woerndle S, Bartmann P (1994) The effect of three surfactant preparations on in vitro lymphocyte functions. J Perinat Med 22:119–128
Wright JR (1997) Immunomodulatory functions of surfactant. Physiol Rev 77:931–962
Wright JR (2003) Pulmonary surfactant: a front line of lung host defense. J Clin Invest 111:1453–1455
Wright JR (2004) Host defense functions of pulmonary surfactant. Biol Neonate 85:326–332
Wright JR (2005) Immunoregulatory functions of surfactant proteins. Nat.Rev.Immunol. 5:58–68
Wright SM, Hockey PM, Enhorning G, Strong P, Reid KB, Holgate ST, Djukanovic R, Postle AD (2000) Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol 89:1283–1292
Yao LJ, Fraher LJ, Veldhuizen RA, Samuelson S, Borron P, Malloy J, McCaig L, Lewis JF (2001) Effects of alveolar surfactant aggregates on T-lymphocyte proliferation. Biochim Biophys Acta 1535:266–274
Yong SJ, Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH (2003) Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun 71:1662–1671
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erpenbeck, V.J., Krug, N. & Hohlfeld, J.M. Therapeutic use of surfactant components in allergic asthma. Naunyn-Schmied Arch Pharmacol 379, 217–224 (2009). https://doi.org/10.1007/s00210-008-0354-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-008-0354-z